Search by Drug Name or NDC

    NDC 63824-0266-66 Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain 650; 400; 10 mg/20mL; mg/20mL; mg/20mL Details

    Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain 650; 400; 10 mg/20mL; mg/20mL; mg/20mL

    Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by RB Health (US) LLC. The primary component is ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 63824-0266
    Product ID 63824-266_deab804f-feff-c95c-e053-2995a90af4f6
    Associated GPIs 43996703500930
    GCN Sequence Number 067923
    GCN Sequence Number Description guaifen/phenyleph/acetaminophn LIQUID 10-650/20 ORAL
    HIC3 B3N
    HIC3 Description DECONGESTANT-ANALGESIC-EXPECTORANT COMBINATION
    GCN 30574
    HICL Sequence Number 023719
    HICL Sequence Number Description GUAIFENESIN/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Brand
    Proprietary Name Maximum Strength Mucinex Sinus-Max Severe Congestion and Pain
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acetaminophen, Guaifenesin, and Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 400; 10
    Active Ingredient Units mg/20mL; mg/20mL; mg/20mL
    Substance Name ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name RB Health (US) LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 63824-0266-66 (63824026666)

    NDC Package Code 63824-266-66
    Billing NDC 63824026666
    Package 180 mL in 1 BOTTLE (63824-266-66)
    Marketing Start Date 2018-03-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL cea08797-1d53-4434-be1a-144f2ded5f9d Details

    Revised: 5/2022